Alchemy Medical Writing Ltd

Alchemy Medical Writing Ltd is a medical writing agency specializing in regulatory documentation and medical communications for pharmaceutical and biotechnology companies. The company operates with a team of EMWA-member medical writers who possess over 100 years of collective experience in the field.

The agency provides two primary service lines: regulatory writing for drug development documentation that meets global compliance standards, and medical communications including publications, educational materials, and patient engagement content. Their regulatory writers are GCP-trained, while medical communications writers hold ABPI training. A growing number of team members have earned CMPP (Certified Medical Publication Professional) certification.

Alchemy serves clients ranging from clinical-stage biotechnology startups to established pharmaceutical companies and larger medical communications agencies. Notable work includes supporting multi-year oncology platform studies, publications in high-impact journals like Lancet Respiratory Medicine, and first-in-human study documentation for novel treatments.

Consider Alchemy Medical Writing when you need specialized pharmaceutical writing expertise backed by formal credentials and extensive collective experience. The agency's dual capability in both regulatory documentation and medical communications allows them to support multiple phases of drug development within a single engagement.

Their work with clinical-stage biotech companies suggests capability to handle complex, novel therapeutic approaches, while their agency partnerships indicate ability to integrate into existing workflows. Expect a team approach with appropriate credentials for each project type and understanding of global regulatory requirements.

Alchemy Medical Writing operates exclusively within the pharmaceutical and biotechnology sectors of healthcare. Their regulatory writing services support drug development from early clinical trials through marketing authorization applications, ensuring compliance with global regulatory requirements including ICH guidelines. The medical communications practice focuses on scientific publications, congress materials, and healthcare professional education specific to pharmaceutical products.

Their healthcare expertise centers on translating complex clinical and scientific data into regulatory-compliant documents, peer-reviewed publications, and evidence-based communications for healthcare professionals. All work adheres to pharmaceutical industry standards including Good Publication Practices and ICMJE recommendations.

Ideal clients are pharmaceutical or biotechnology companies in clinical development stages requiring regulatory documentation support, medical publication assistance, or healthcare professional education materials. Clinical-stage biotech companies with novel therapeutic approaches benefit from their specialized expertise, as do established pharma organizations seeking external writing resources for specific projects or congresses.